Reports on data collected during on-site audits of source documents in the Cancer and Leukemia Group B (CALGB). Audit reports in four audit cycles; Results of institutional audits conducting clinical trials in cancer treatment; Scientific improprieties in CALGB clinical trials; Protocol compliance in assessing patient eligibility; Administrative compliance to consent forms; Review board approval.